- Home
- JNVR vs PSTV Comparison
JNVR vs PSTV Comparison
Compare JNVR & PSTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JNVR
- PSTV
- Stock Information
- Founded
- JNVR 2018
- PSTV 1996
- Country
- JNVR United States
- PSTV United States
- Employees
- JNVR N/A
- PSTV N/A
- Industry
- JNVR Finance: Consumer Services
- PSTV Medical/Dental Instruments
- Sector
- JNVR Finance
- PSTV Health Care
- Exchange
- JNVR Nasdaq
- PSTV Nasdaq
- Market Cap
- JNVR 7.3M
- PSTV 6.3M
- IPO Year
- JNVR 2023
- PSTV N/A
- Fundamental
- Price
- JNVR $5.91
- PSTV $1.22
- Analyst Decision
- JNVR
- PSTV Strong Buy
- Analyst Count
- JNVR 0
- PSTV 2
- Target Price
- JNVR N/A
- PSTV $13.50
- AVG Volume (30 Days)
- JNVR 23.6K
- PSTV 34.6K
- Earning Date
- JNVR 11-06-2024
- PSTV 03-04-2025
- Dividend Yield
- JNVR N/A
- PSTV N/A
- EPS Growth
- JNVR N/A
- PSTV N/A
- EPS
- JNVR N/A
- PSTV N/A
- Revenue
- JNVR $1,820,969.00
- PSTV $5,725,000.00
- Revenue This Year
- JNVR N/A
- PSTV $32.12
- Revenue Next Year
- JNVR N/A
- PSTV N/A
- P/E Ratio
- JNVR N/A
- PSTV N/A
- Revenue Growth
- JNVR N/A
- PSTV 52.63
- 52 Week Low
- JNVR $3.37
- PSTV $0.93
- 52 Week High
- JNVR $11.84
- PSTV $2.67
- Technical
- Relative Strength Index (RSI)
- JNVR 57.98
- PSTV 52.68
- Support Level
- JNVR $5.06
- PSTV $1.16
- Resistance Level
- JNVR $6.70
- PSTV $1.24
- Average True Range (ATR)
- JNVR 0.72
- PSTV 0.08
- MACD
- JNVR -0.01
- PSTV 0.01
- Stochastic Oscillator
- JNVR 63.76
- PSTV 48.00
About JNVR Janover Inc.
Janover Inc is a B2B fintech marketplace providing a platform for commercial property borrowers and lenders. It provides a technology platform that connects commercial mortgage borrowers looking for debt to refinance, build, or buy commercial property including apartment buildings to commercial property lenders including banks, credit unions, REITs, debt funds, and more looking to deploy capital into commercial mortgages. The firm caters to two consumer segments: lenders and borrowers. It derives the majority of its revenue from transaction fees.
About PSTV PLUS THERAPEUTICS Inc.
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).